Literature DB >> 9591027

Treatment of benign and low-grade malignant intramedullary chondroid tumours with curettage and cryosurgery.

H W Schreuder1, M Pruszczynski, R P Veth, J A Lemmens.   

Abstract

AIMS: To shed light on the controversy surrounding the methods of evaluating, staging and final treatment of intramedullary chondroid lesions. Controversy particularly exists for enchondroma and low-grade chondrosarcoma located in the extremities, because their accurate distinction is hampered by their radiographical and histological similarity.
METHODS: Since 1991 we have treated 22 patients (mean age: 39.6 years) with 26 lesions (three chondroblastomas, 14 enchondromas and nine grade 1 chondrosarcomas) with curettage, cryosurgery and bone grafting.
RESULTS: After a mean follow-up of 26 months no recurrences were observed. Complications consisted of two post-operative fractures, one wound infection and one intraoperative venous gas embolism. All bone grafts incorporated, resulting in full weight-bearing capacity and excellent functional results.
CONCLUSION: The usefulness of a combination of curettage and cryosurgery as adjuvant therapy is considered to be equal to marginal resection according to orthopaedic oncological principles. The pre-operative assessment of these lesions and cryosurgical technique is described in detail.

Entities:  

Mesh:

Year:  1998        PMID: 9591027     DOI: 10.1016/s0748-7983(98)91459-7

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  24 in total

1.  [Changes in stability after cryosurgical treatment of long tubular bones. An animal experiment study].

Authors:  F Popken; A Niehoff; F Emrich; D Blaecker; M Bosse; J Michael; G-P Brüggemann; P Eysel
Journal:  Unfallchirurg       Date:  2004-02       Impact factor: 1.000

2.  [Therapy of enchondroma in long bones].

Authors:  H Steckel; M Oldenburg; R T Müller
Journal:  Unfallchirurg       Date:  2005-06       Impact factor: 1.000

3.  [Comment on the work "Therapy of enchondroma in long bones" (H. Steckel, M. Oldenburg, R.T. Müller)].

Authors:  W Mutschler; W Sienel
Journal:  Unfallchirurg       Date:  2005-06       Impact factor: 1.000

4.  Curettage and cryosurgery for low-grade cartilage tumors is associated with low recurrence and high function.

Authors:  David G Mohler; Richard Chiu; David A McCall; Raffi S Avedian
Journal:  Clin Orthop Relat Res       Date:  2010-06-24       Impact factor: 4.176

5.  Intralesional treatment versus wide resection for central low-grade chondrosarcoma of the long bones.

Authors:  Edwin F Dierselhuis; Krista A Goulding; Martin Stevens; Paul C Jutte
Journal:  Cochrane Database Syst Rev       Date:  2019-03-07

6.  A reproducible and simple grading system for classical chondrosarcomas. Analysis of 35 chondrosarcomas and 16 enchondromas with emphasis on recurrence rate and radiological and clinical data.

Authors:  Heike Welkerling; Susanne Kratz; Volker Ewerbeck; Günter Delling
Journal:  Virchows Arch       Date:  2003-09-25       Impact factor: 4.064

7.  Extended intralesional treatment versus resection of low-grade chondrosarcomas.

Authors:  Chad Aarons; Benjamin K Potter; Sheila C Adams; J David Pitcher; H Thomas Temple
Journal:  Clin Orthop Relat Res       Date:  2009-01-14       Impact factor: 4.176

8.  Grade I chondrosarcoma of bone: the Münster experience.

Authors:  Arne Streitbürger; Helmut Ahrens; Maurice Balke; Horst Buerger; Winfried Winkelmann; Georg Gosheger; Jendrik Hardes
Journal:  J Cancer Res Clin Oncol       Date:  2008-10-15       Impact factor: 4.553

9.  Treatment of hand enchondroma with injectable calcium phosphate cement: a series of eight cases.

Authors:  Mohammad Al Rajeh; Juan José Hidalgo Diaz; Sybille Facca; Anne Sophie Matheron; Stéphanie Gouzou; Philippe Liverneaux
Journal:  Eur J Orthop Surg Traumatol       Date:  2016-12-09

10.  No recurrences in selected patients after curettage with cryotherapy for grade I chondrosarcomas.

Authors:  Badio S Souna; Nicolas Belot; Hélène Duval; Frantz Langlais; Hervé Thomazeau
Journal:  Clin Orthop Relat Res       Date:  2010-01-07       Impact factor: 4.176

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.